Expression of functional decay-accelerating factor (CD55) in transgenic mice protects against human complement-mediated attack

Transplantation

Volumn 61, Issue 4, 1996, Pages 582-588

  Van Denderen, Bryce J W ^a   Pearse, Martin J ^f   Katerelos, Marina ^f   Nottle, Mark B ^b   Du, Zhong Tau ^b   Aminian, Atousa ^c   Adam, William R ^c   Shenoy Scaria, Amiya ^d   Lublin, Douglas M ^d   Shinkel, Trixie A ^f   D'Apice, Anthony J F ^e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Bresatec Ltd   (Australia)

^c AUSTIN HEALTH   (Australia)

^d WASHINGTON UNIVERSITY   (United States)

^e ST VINCENT S HOSPITAL   (Australia)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT MEMBRANE ATTACK COMPLEX; DECAY ACCELERATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPLEMENT DEPENDENT CYTOTOXICITY; FLOW CYTOMETRY; HEART TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

ANIMALS; ANTIGENS, CD55; BASE SEQUENCE; COMPLEMENT ACTIVATION; COMPLEMENT C3C; CYTOTOXICITY, IMMUNOLOGIC; GENE TRANSFER TECHNIQUES; H-2 ANTIGENS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, TRANSGENIC; MICROINJECTIONS; MOLECULAR SEQUENCE DATA; MYOCARDIUM; PERFUSION; PROMOTER REGIONS (GENETICS); SPLEEN; TRANSGENES; TRANSPLANTATION, HETEROLOGOUS;

EID: 9044221370     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602270-00012     Document Type: Article

References (29)

1. Platt JL, Bach FH. The barrier to xenotransplantation. Transplantation 1991; 52: 937.
2. Bach FH. Xenotransplantation: a view to the future. Transplant Proc 1993; 25: 25.
3. d'Apice AJF, Pearse MJ. Xenotransplantation. In: Tilney NL, Strom TB, Paul LC, eds. Transplantation biology: cellular and molecular aspects. New York: Raven, (in press).
4. Morgan BP, Meri S. Membrane proteins that protect against complement lysis. Springer Semin Immunopathol 1994; 15: 369.
5. Dalmasso AP, Vercellotti GM, Platt JL, Bach FH. Inhibition of complement-mediated endothelial cell cytotoxicity by decay-accelerating factor. Transplantation 1991; 52: 530.
6. Platt JL, Vercelloti GM, Dalmasso AP, et al. Transplantation of discordant xenografts: a review of progress. Immunol Today 1990; 11: 450.
7. Brinster RL, Chen HY, Trumbauer M, Senear AW, Warren R, Palmiter RD. Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell 1981; 27: 223.
8. Winoto A, Baltimore D. A novel, inducible and T cell-specific enhancer located at the 3′ end of the T cell receptor α locus. EMBO J 1989; 8: 729.
9. b promoter: enhancer-like sequences and their role in the regulation of class I gene expression. Cell 1986; 44: 261.
10. Post TW, Arce MA, Liszewski MK, Thompson ES, Atkinson JP, Lublin DM. Structure of the gene for human complement protein decay-accelerating factor. J Immunol 1990; 144: 740.
11. Medof ME, Lubin DM, Holers VM, et al. Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Natl Acad Sci USA 1987; 84: 2007.
12. Fuhlbrigge RC, Fine SM, Unanue ER, Chaplin DD. Expression of membrane interleukin 1 fibroblasts transfected with murine pro-interleukin 1α cDNA. Proc Natl Acad Sci USA 1988; 85: 5649.
13. Hogan B, Constantini F, Lacy E, eds. Manipulating the mouse embryo: a laboratory manual. New York: Cold Spring Harbor Laboratory, 1986: 151.
14. Panaccio M, Georgesz M, Lew AM. FoLT PCR: A simple PCR protocol for amplifying DNA directly from whole blood. Biotechniques 1993; 14: 238.
15. Coyne KE, Hall SE, Thompson ES, et al. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay-accelerating factor. J Immunol 1992; 149: 2906.
16. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S. Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 1994; 46: 89.
17. Morello D, Gachelin G, Dubois Ph, Tanigaki N, Pressman D, Jacob F. Absence of reaction of a xenogeneic anti-H-2 serum with mouse embryonal carcinoma cells. Transplantation 1978; 26: 119.
18. Somerville CA, Kyriazis AG, McKensie A, Allison J, Pearse MJ, d'Apice AJF. Functional expression of human CD59 in transgenic mice. Transplantation 1994; 58: 1430.
19. Morello D, Moore G, Salmon AM, Yaniv M, Babinet C. Studies on the expression of an H-2K/human growth hormone fusion gene in giant transgenic mice. EMBO J 1986; 5: 1877.
20. Kinoshita T, Medof ME, Silber R, Nussenzweig V. Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 1985; 162: 75.
21. bm1 class I MHC genes. Nucleic Acid Res 1990; 18: 4185.
22. Fodor WL, Williams BL, Matis LA, et al. Expression of a functional human complement inhibitor in a transgenic pig as a model for the prevention of xenogeneic hyperacture organ rejection. Proc Natl Acad Sci USA 1994; 91: 11, 153.
23. Oglesby TJ, Allen CJ, Liszewski MK, White DJG, Atkinson JP. Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism. J Exp Med 1992; 175: 1547.
24. White DJG, Oglesby T, Liszewski MK, et al. Expression of human decay accelerating factor or membrane cofactor protein genes on mouse cells inhibits lysis by human complement. Transplant Proc 1992; 24: 474.
25. Mulder LCF, Mora M, Ciccopiedi E, et al. Mice transgenic for human CD46 and CD55 are protected from human complement attack. Transplant Proc 1995; 27: 333.
26. McCurry KR, Kooyman DL, Diamond LE, Byrne GW, Logan JS, Platt JL. Transgenic expression of human complement regulatory proteins in mice results in diminished complement deposition during organ xenoperfusion. Transplantation 1995; 59: 1177.
27. Cozzi E, Langford GA, Richards A, et al. Expression of human decay accelerating factor in transgenic pigs. Transplant Proc 1994; 26: 1402.
28. Langford GA, Yannoutsos N, Cozzi E, et al. Production of pigs transgenic for human decay accelerating factor. Transplant Proc 1994; 26: 1400.
29. McCurry KR, Kooyman DL, Alvarado CG, et al. Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injury. Nature Medicine 1995; 1: 423.